DAMORA THERAPEUTICS INC (DMRA) Forecast, Price Target & Analyst Ratings

NASDAQ:DMRA • US36322Q2066

Current stock price

26.06 USD
+0.56 (+2.2%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DAMORA THERAPEUTICS INC (DMRA).

Forecast Snapshot

Consensus Price Target

Price Target
$46.07
+ 76.78% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.40
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.45%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$46.07
Upside
+ 76.78%
From current price of $26.06 to mean target of $46.07, Based on 11 analyst forecasts
Low
$40.40
Median
$45.90
High
$57.75

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for DMRA. The average price target is 46.07 USD. This implies a price increase of 76.78% is expected in the next year compared to the current price of 26.06.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

DMRA Current Analyst RatingDMRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

DMRA Historical Analyst RatingsDMRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.45%
DMRA was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about DMRA.
In the previous month the buy percentage consensus was at a similar level.
DMRA was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-24RBC CapitalInitiate Outperform
2026-03-25Evercore ISI GroupInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.40
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
13.04%
EPS (3 Months)
N/A

Next Earnings Summary

DMRA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.4 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
DMRA revenue by date.DMRA revenue by date.
N/AN/AN/AN/AN/AN/AN/A
758.57%		N/A
140.27%
EBITDA
YoY % growth
DMRA ebitda by date.DMRA ebitda by date.
N/AN/AN/A-52.21M
-39.71%		-61.17M
-17.16%		-36.188M
40.84%		-16.876M
53.37%		-36.54M
-116.52%		N/A
-352.64%		N/A
-4.30%		N/A
-4.32%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
DMRA ebit by date.DMRA ebit by date.
-12.91M-22.18M
-71.80%		-33.64M
-51.67%		-52.23M
-55.26%		-61.21M
-17.19%		-36.457M
40.44%		-16.897M
53.65%		-36.562M
-116.38%		N/A
-127.08%		N/A
-43.66%		N/AN/AN/A
-18.75%		N/A
0.70%		N/A
66.08%		N/A
372.92%
Operating Margin
DMRA operating margin by date.DMRA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
DMRA eps by date.DMRA eps by date.
N/AN/AN/A-51.25
60.57%		N/A
-24.87%		-36.50
42.97%		-17.62
51.73%		N/A
94.46%		N/A
-45.99%		N/A
-26.97%		N/A
-10.71%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.40-0.34-0.36-0.40
-114.86%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-25.784M
-892.09%		-27.448M
-702.34%		-28.784M
-812.05%		-31.889M
-16.44%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DMRA Yearly Revenue VS EstimatesDMRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2031 2032 2033 200M 400M 600M
DMRA Yearly EPS VS EstimatesDMRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 -20 -40 -60 -80 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.80%
EPS Next 5 Year
17.19%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-123.85%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DAMORA THERAPEUTICS INC / DMRA Forecast FAQ

What is the average price target for DAMORA THERAPEUTICS INC (DMRA) stock?

11 analysts have analysed DMRA and the average price target is 46.07 USD. This implies a price increase of 76.78% is expected in the next year compared to the current price of 26.06.

When does DAMORA THERAPEUTICS INC (DMRA) report earnings?

DAMORA THERAPEUTICS INC (DMRA) will report earnings on 2026-05-06.

What are the consensus estimates for DMRA stock next earnings?

The consensus EPS estimate for the next earnings of DAMORA THERAPEUTICS INC (DMRA) is -0.4 USD and the consensus revenue estimate is 0 USD.